Cargando…
New Immunosuppressive Therapies in Uveitis Treatment
Uveitis is an inflammatory process that initially starts in the uvea, but can also affect other adjacent eye structures, and is currently the fourth cause of blindness in developed countries. Corticoids are probably the most widespread treatment, but resorting to other immunosuppressive treatments i...
Autores principales: | Mérida, Salvador, Palacios, Elena, Navea, Amparo, Bosch-Morell, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581271/ https://www.ncbi.nlm.nih.gov/pubmed/26270662 http://dx.doi.org/10.3390/ijms160818778 |
Ejemplares similares
-
Macrophages and Uveitis in Experimental Animal Models
por: Mérida, Salvador, et al.
Publicado: (2015) -
Oxidative Stress in Myopia
por: Francisco, Bosch-Morell, et al.
Publicado: (2015) -
An Anti-Interleukin-2 Receptor Drug Attenuates T- Helper 1 Lymphocytes-Mediated Inflammation in an Acute Model of Endotoxin-Induced Uveitis
por: Mérida, Salvador, et al.
Publicado: (2014) -
Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model
por: Mérida, Salvador, et al.
Publicado: (2018) -
Lipid Peroxidation in Subretinal Fluid: Some Light on the Prognosis Factors
por: Bosch-Morell, Francisco, et al.
Publicado: (2021)